Cargando…
Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores
There is the potential for high-dimensional information about patients collected in clinical trials (such as genomic, imaging, and data from wearable technologies) to be informative for the efficacy of a new treatment in situations where only a subset of patients benefits from the treatment. The ada...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611900/ https://www.ncbi.nlm.nih.gov/pubmed/32662542 http://dx.doi.org/10.1002/sim.8665 |